99 related articles for article (PubMed ID: 298417)
1. Role of the radiotherapist in orbital disease.
Henk JM
Trans Ophthalmol Soc U K (1962); 1979 Jul; 99(2):234-5. PubMed ID: 298417
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy of malignant tumours of the orbit (author's transl)].
Walther E; Gloor B
Klin Monbl Augenheilkd; 1979 Jun; 174(6):959-68. PubMed ID: 480852
[No Abstract] [Full Text] [Related]
3. Radiotherapy of primary malignant tumours of the orbit.
Lederman M
Mod Probl Ophthalmol; 1975; 14():170-6. PubMed ID: 170508
[No Abstract] [Full Text] [Related]
4. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
5. Radiation therapy: orbital tumors.
Marwaha G; Macklis R; Singh AD
Dev Ophthalmol; 2013; 52():94-101. PubMed ID: 23989130
[TBL] [Abstract][Full Text] [Related]
6. [Radiotherapy in the treatment of orbital rhabdomyosarcoma].
Muto P; Ravo V
Radiol Med; 1992 Mar; 83(3):273-5. PubMed ID: 1579679
[TBL] [Abstract][Full Text] [Related]
7. Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma.
Woolf DK; Ahmed M; Plowman PN
Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):339-44. PubMed ID: 22521959
[TBL] [Abstract][Full Text] [Related]
8. Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa.
Kennerdell JS; Flores NE; Hartsock RJ
Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):129-33. PubMed ID: 10189642
[TBL] [Abstract][Full Text] [Related]
9. Orbital rhabdomyosarcoma: multidisciplinary treatment experience.
Forstner D; Borg M; Saxon B
Australas Radiol; 2006 Feb; 50(1):41-5. PubMed ID: 16499726
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiotherapy for unilateral orbital lymphoma and orbital pseudo-tumors: a planning study.
Chino K; Tanyi JA; Stea B
Med Dosim; 2009; 34(1):57-62. PubMed ID: 19181257
[TBL] [Abstract][Full Text] [Related]
11. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
[TBL] [Abstract][Full Text] [Related]
12. [Normal tissue tolerance to external beam radiation therapy: eye structures].
Marchand V; Dendale R
Cancer Radiother; 2010 Jul; 14(4-5):277-83. PubMed ID: 20615743
[TBL] [Abstract][Full Text] [Related]
13. Orbital rhabdomyosarcoma in children.
Sagerman RH; Tretter P; Ellsworth RM
Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(4):OP602-5. PubMed ID: 4212217
[No Abstract] [Full Text] [Related]
14. Radiotherapy for orbital lymphoma : outcome and late effects.
Bischof M; Karagiozidis M; Krempien R; Treiber M; Neuhof D; Debus J; Zierhut D
Strahlenther Onkol; 2007 Jan; 183(1):17-22. PubMed ID: 17225941
[TBL] [Abstract][Full Text] [Related]
15. Primary orbital plasmacytoma mimicking lacrimal gland tumor.
Bhadauria M; Ranjan P; Mishra D
Orbit; 2014 Aug; 33(4):305-7. PubMed ID: 24832726
[TBL] [Abstract][Full Text] [Related]
16. Osteogenic sarcoma after orbital radiation rhabdomyosarcoma.
Yip CC; Kersten RC; McCulley TJ; Ballard ET; Kulwin DR
Ophthalmology; 2003 Oct; 110(10):1996-9. PubMed ID: 14522778
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.
Nam H; Ahn YC; Kim YD; Ko Y; Kim WS
Radiother Oncol; 2009 Feb; 90(2):236-41. PubMed ID: 18950885
[TBL] [Abstract][Full Text] [Related]
18. [Classification of the orbital tumours (author's transl)].
Babel J
Klin Monbl Augenheilkd; 1979 Jun; 174(6):910-5. PubMed ID: 225604
[No Abstract] [Full Text] [Related]
19. [Clinical presentation, differential diagnosis and treatment of lacrimal gland tumours].
Hajda M; Korányi K; Salomváry B; Bajcsay A
Magy Onkol; 2005; 49(1):65-70. PubMed ID: 15902337
[TBL] [Abstract][Full Text] [Related]
20. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
